Scale of R&D Expenditure
First written in FY2024-Q1. . Latest entry: FY2026.
49 other companies' latest entry also says "Other".
- FY2026Full-year R&D spending disclosedAnnual report
「During the fiscal year, the Group incurred ¥155 million in R&D expenses and ¥389 million in cost of sales related to commissioned R&D, for total R&D spending of ¥544 million.」
Full-year R&D spending totaled ¥544 million, comprising ¥155 million of in-house R&D expenses and ¥389 million of cost of sales related to commissioned R&D. - FY2026-H1Interim-period R&D spending increasedAnnual report
「During the six months ended September 30, the Group spent ¥85 million on in-house R&D and ¥198 million on commissioned R&D, for total R&D spending of ¥284 million.」
Interim-period R&D spending totaled ¥284 million, comprising ¥85 million of in-house R&D and ¥198 million of commissioned R&D. - FY2025-H1Interim-period R&D spending disclosedAnnual report
「During the six months ended September 30, the Group spent ¥95 million on in-house R&D and ¥71 million on commissioned R&D, for total R&D spending of ¥167 million.」
Interim-period in-house R&D spending was ¥95 million, commissioned R&D spending was ¥71 million and total spending was ¥167 million. - FY2024-Q3Nine-month R&D spending disclosedAnnual report
「During the nine months ended December 31, the Group spent ¥123 million on in-house R&D and ¥170 million on commissioned R&D, for total R&D spending of ¥293 million.」
Nine-month in-house R&D spending was ¥123 million, commissioned R&D spending was ¥170 million and total spending was ¥293 million. - FY2024-Q2First-half R&D spending disclosedAnnual report
「During the six months ended September 30, the Group spent ¥90 million on in-house R&D and ¥45 million on commissioned R&D, for total R&D spending of ¥136 million.」
First-half in-house R&D spending was ¥90 million, commissioned R&D spending was ¥45 million and total spending was ¥136 million. - FY2024-Q1First statedAnnual report
「During the three months ended June 30, the Group spent ¥48 million on in-house R&D and ¥9 million on commissioned R&D, for total R&D spending of ¥57 million.」
In-house R&D spending was ¥48 million, commissioned R&D spending was ¥9 million and total spending was ¥57 million.